J Low Genit Tract Dis. 2014;18(1):1-7. In a clinical setting, this combination of maintained sensitivity with increased specificity would lead to fewer office visits and procedures. Our cost analysis ...
Helix BioPharma announces positive phase II clinical results with its Topical Interferon Alpha-2b AURORA, ON, March 30 - Helix BioPharma Corp. Helix today announced positive results from its phase II ...
(HealthDay News) – DNA-based testing with Hybrid Capture 2 (HC2) assay is more accurate than repeat cytology in identifying women with cervical cancer when their initial Pap smear shows atypical ...
“Overall, a sexually active adolescent’s chance of developing a persistent LSIL that progresses to a more advanced stage is approximately three in 100,” Moscicki said. Based on those findings, ...
Comparison of different adjuvant therapy after radical surgery in early stage cervical carcinoma: A 3-arm randomized control study. Background: Few studies have reported the burden of Pap ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback